Tello-Medina RI, Verdiguel-Sotelo K

Language: Spanish
References: 17
Page: 216-221
PDF size: 246.23 Kb.

ABSTRACT

COVID-19 is a disease that can be asymptomatic or characterized by cough, shortness of breath, and fever, causing pneumonia in some cases that can lead to death. There is currently no evidence that coronaviruses can transmit by transplanting tissue, cells, or transfusions, so measures in response to this are precautions, motivating continuous regulatory updating for the corneal tissue management procedure and corneal transplantation, based in the criteria adopted by various associations. This provides the security of obtaining corneal tissue through strict eligibility criteria supported by guidelines issued and studied, thus guaranteeing the protection of recipient patients. You must perform RT-PCR both in the donor (before death and up to 24 hours after death) as in the recipients. Although at the moment there is a temporary suspension of organ and tissue donation and transplantation programs nationwide and only corneal transplants are considered in urgent situations, the evaluation of the conditions in which the gradual start of the normal activity of corneal donations-procurement and transplant activity, minimizing the risk to recipients and health personnel involved.

REFERENCES

1. Abd El-Aziz TM, Stockand JD. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status. Infect Genet Evol. 2020; 83: 104327.

2. Centro para el Control de Enfermedades (EE.UU). Nuevo coronavirus 2019 [consultado 16/05/2020]. Disponible en: https://www.cdc.gov/coronavirus/COVID-2019/hcp/clinical-criteria.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2FCOVID-2019%2Fclinical-criteria.html

3. Rothe C, Schunk M, Sothmann P et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020; 382 (10): 970‐971. doi: 10.1056/NEJMc2001468.

4. Organización Mundial de la Salud. Vigilancia global de la infección humana con nuevos coronavirus (COVID-2019). [Consultado 18/05/2020]. Disponible en: https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(COVID-2019)

5. U.S. Food and Drug Administration. Important Information for Human Cell, Tissue, or Cellular or Tissue-based Product (HCT/P) Establishments Regarding the 2019 Novel Coronavirus Outbreak. 2020. [Consultado 18/05/2020] Disponible en: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-information-human-cell-tissue-or-cellular-or-tissue-based-product-hctp-establishments

6. Global Alliance of Eye Bank Associations: Coronavirus (COVID-2019) and Ocular Tissue Donation, 25th March 2020. [Consultado 18/05/2020]. Disponible en: http://www.gaeba.org/2020/alert-coronavirus-2019-ncov-and-ocular-tissue-donation/

7. The Transplantation Society. Guidance on Coronavirus Disease 2019 (COVID-19) for Transplant Clinicians. [Consultado 18/05/2020] Disponible en: https://tts.org/23-tid/tid-news/657-tid-update-and-guidance-on-2019-novel-coronavirus-2019-ncov-for-transplant-id-clinicians

8. Colavita F, Lapa D, Carletti F et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020; M20-1176. doi: 10.7326/M20-1176. Available in: https://annals.org/aim/fullarticle/2764963/sars-cov-2-isolation-from-ocular-secretions-patient-covid-19

9. Sociedad Americana de Oftalmología. Alerta de miembros. [Consultado 18/05/2020] Disponible en: https://mcusercontent.com/0412f950aa96d1122aaf84b86/files/23643b56-fcdf-41ec-a7b2-512182045453/AAO_Member_Alert_29_January_2020.pdf

10. Departamento de Salud del Gobierno Australiano. Lo que necesita saber sobre el coronavirus (COVID-19). [Consultado 19/05/2020] Disponible en: https://www.health.gov.au/news/health-alerts/novel-coronavirus-2019-ncov-health-alert/what-you-need-to-know-about-coronavirus-covid-19#symptoms

11. Chen L, Liu M, Zhang Z et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020; 104 (6): 748‐751. doi: 10.1136/bjophthalmol-2020-316304.

12. Desautels JD, Moshirfar M, Martheswaran T, Shmunes KM, Ronquillo YC. Risks posed to corneal transplant recipients by COVID-19-affected donors [published online ahead of print, 2020 May 6]. Ophthalmol Ther. 2020; 1‐9. doi: 10.1007/s40123-020-00254-w.

13. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020; 104 (3): 246‐251. doi: 10.1016/j.jhin.2020.01.022.

14. Information About COVID-19 (Coronavirus) is being released rapidly. We are posting updates here as we get them. [Consultado 19/05/2020] Disponible en: http://restoresight.org

15. Zhao J, Yuan Q, Wang H et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa344.

16. Centers for Disease Control and Prevention, Coronavirus (COVID-19) CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel. [Consultado 19/05/2020] Disponible en: http://cdc.gov

17. Aburto-Morales JS, Romero-Méndez J, Lucio-García CA, Madrigal-Bustamante JA, grupo de expertos del Subsistema Nacional de Trasplante. México ante la pandemia por SARS-CoV-2 (COVID-19) y las recomendaciones al Subsistema Nacional de Donación y trasplantes. [Publicación en revisión]